Iveric Bio Inc
(ISEE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,889 | 116,639 | 131,201 | 135,208 | 145,991 |
| Receivables | 1,765 | N/A | N/A | N/A | N/A |
| TOTAL | $110,591 | $119,034 | $133,287 | $137,263 | $147,910 |
| Non-Current Assets | |||||
| PPE Net | 252 | 292 | 335 | 379 | 424 |
| Other Non-Current Assets | 2,765 | 4,770 | 3,543 | 3,315 | 3,327 |
| TOTAL | $3,017 | $5,062 | $3,878 | $3,694 | $3,751 |
| Total Assets | $113,608 | $124,096 | $137,165 | $140,957 | $151,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,241 | 2,987 | 5,869 | 4,614 | 3,994 |
| Accrued Expenses | 7,645 | 5,910 | 7,337 | 5,916 | 5,137 |
| TOTAL | $11,875 | $9,882 | $13,206 | $10,530 | $9,131 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 245 | 0 | 125,000 | 125,000 |
| TOTAL | $N/A | $245 | $N/A | $125,000 | $125,000 |
| Total Liabilities | $11,875 | $10,127 | $13,206 | $135,530 | $134,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,563 | 41,477 | 41,422 | 41,267 | 36,198 |
| Common Shares | 41 | 41 | 41 | 36 | 36 |
| Retained earnings | -448,611 | -434,168 | N/A | -525,781 | -511,036 |
| Other shareholders' equity | 0 | 0 | -421,667 | 0 | 0 |
| TOTAL | $101,733 | $113,969 | $123,959 | $5,427 | $17,530 |
| Total Liabilities And Equity | $113,608 | $124,096 | $137,165 | $140,957 | $151,661 |